BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, an
AstraZeneca sets out $15 billion China investment during Starmer visit
AstraZeneca's Strategic Investment in China
BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, an announcement made during British Prime Minister Keir Starmer's visit to Beijing.
Details of the Investment
The announcement marks the biggest deal so far during the trip, as Britain seeks to strengthen ties with Beijing at a time of strained relations with Washington.
Implications for UK-China Relations
(Reporting by Andrew MacAskill in Beijing and Maggie Fick in LondonAdditional reporting by Andrew Silver in ShanghaiEditing by Muvija M)


